14 September 2016 : Meta-Analysis
Intravesical Botulinum Toxin A Injections for Bladder Pain Syndrome/Interstitial Cystitis: A Systematic Review and Meta-Analysis of Controlled Studies
Junpeng WangACDE, Qiang WangABDE, Qinghui WuBCD, Yang ChenBF, Peng WuADEGDOI: 10.12659/MSM.897350
Med Sci Monit 2016; 22:3257-3267
Abstract
BACKGROUND: The role of intravesical botulinum toxin A (BTX-A) injections in bladder pain syndrome/interstitial cystitis (BPS/IC) has not been clearly defined. The aim of this study was to evaluate high-level evidence regarding the efficacy and safety of BTX-A injections for BPS/IC.
MATERIAL AND METHODS: We conducted a comprehensive search of PubMed, Embase, and Web of Science, and conducted a systematic review and meta-analysis of all available randomized controlled trials (RCTs) and controlled studies assessing BTX-A injections for BPS/IC.
RESULTS: Seven RCTs and 1 retrospective study were identified based on the selection criteria. Pooled analyses showed that although BTX-A was associated with a slightly larger volume of post-void residual urine (PVR) (weighted mean difference [WMD] 10.94 mL; 95% confidence intervals [CI] 3.32 to 18.56; p=0.005), patients in this group might benefit from greater reduction in pelvic pain (WMD –1.73; 95% CI –3.16 to –0.29; p=0.02), Interstitial Cystitis Problem Index (ICPI) scores (WMD –1.25; 95% CI –2.20 to –0.30; p=0.01), and Interstitial Cystitis Symptom Index (ICSI) scores (WMD –1.16; 95% CI –2.22 to –0.11; p=0.03), and significant improvement in daytime frequency of urination (WMD –2.36; 95% CI –4.23 to –0.49; p=0.01) and maximum cystometric capacity (MCC) (WMD 50.49 mL; 95% CI 25.27 to 75.71; p<0.00001). Nocturia, maximal urinary flow rate, dysuria, and urinary tract infection did not differ significantly between the 2 groups.
CONCLUSIONS: Intravesical BTX-A injections might offer significant improvement in bladder pain symptoms, daytime urination frequency, and MCC for patients with refractory BPS/IC, with a slightly larger PVR. Further well-designed, large-scale RCTs are required to confirm the findings of this analysis.
Keywords: Botulinum Toxins, Type A - therapeutic use, Administration, Intravesical, Case-Control Studies, Cystitis, Interstitial - physiopathology, Dysuria - physiopathology, Pain Measurement, Pelvic Pain - physiopathology, Publication Bias, Risk Factors, Urination
Editorial
01 September 2024 : Editorial
Editorial: Reasons for Increasing Global Concerns for the Spread of MpoxDOI: 10.12659/MSM.946343
Med Sci Monit 2024; 30:e946343
In Press
Review article
Long COVID or Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and the Urgent Need to Identify Diagnostic...Med Sci Monit In Press; DOI: 10.12659/MSM.946512
Clinical Research
Intravenous Lidocaine Response as a Predictor for Oral Oxcarbazepine Efficacy in Neuropathic Pain Syndrome:...Med Sci Monit In Press; DOI: 10.12659/MSM.945612
Review article
Cariprazine in Psychiatry: A Comprehensive Review of Efficacy, Safety, and Therapeutic PotentialMed Sci Monit In Press; DOI: 10.12659/MSM.945411
Clinical Research
Comparison of Remimazolam and Dexmedetomidine for Sedation in Awake Endotracheal Intubation in Scoliosis Su...Med Sci Monit In Press; DOI: 10.12659/MSM.944632
Most Viewed Current Articles
17 Jan 2024 : Review article 6,053,124
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research 1,840,708
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 693,001
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
07 Jan 2022 : Meta-Analysis 257,439
Efficacy and Safety of Light Therapy as a Home Treatment for Motor and Non-Motor Symptoms of Parkinson Dise...DOI :10.12659/MSM.935074
Med Sci Monit 2022; 28:e935074